Clinical trial
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
NCT06532890 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
- Lead sponsor
- Northwestern University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 6, 2025
- Completion date
- October 1, 2029
- Enrollment
- 150 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac failure, graft rejection